A Global Biomedical R&D Fund and Mechanism for Innovations of Public Health Importance

PLoS Medicine

Volumn 12, Issue 5, 2015, Pages

  Balasegaram, Manica ^a   Bréchot, Christian ^b   Farrar, Jeremy ^c   Heymann, David ^d   Ganguly, Nirmal ^e   Khor, Martin ^f   Lévy, Yves ^g   Matsoso, Precious ^h   Minghui, Ren ⁱ   Pécoul, Bernard ^j   Peilong, Liu ^k   Tanner, Marcel ^l   Røttingen, John Arne ^m,n  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b INSTITUT PASTEUR   (France)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d ROYAL INSTITUTE OF INTERNATIONAL AFFAIRS   (United Kingdom)

^e JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^f Geneva Academy   (Switzerland)

^g INSERM   (France)

^h NATIONAL DEPARTMENT OF HEALTH   (South Africa)

ⁱ National Health and Family Planning Commission of China   (China)

^j Suisse   (Switzerland)

^k PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^l SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^m UNIVERSITY OF OSLO   (Norway)

ⁿ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EBOLA HEMORRHAGIC FEVER; GLOBAL BIOMEDICAL R AND D FUND; NEGLECTED DISEASE; ORGANIZATION AND MANAGEMENT; PERFORMANCE; PUBLIC HEALTH; WORLD HEALTH ORGANIZATION; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH; HEALTH CARE PLANNING; HUMAN; MEDICAL RESEARCH; MEDICAL TECHNOLOGY;

BIOMEDICAL RESEARCH; BIOMEDICAL TECHNOLOGY; GLOBAL HEALTH; HEALTH PRIORITIES; HUMANS; PUBLIC HEALTH; RESEARCH SUPPORT AS TOPIC;

EID: 84930531752     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001831     Document Type: Article

References (10)

1. Global strategy and plan of action on public health, innovation and intellectual property. Sixty-first World Health Assembly, 19–24 May 2008, Resolution WHA61.21. Geneva: World Health Organization; 2008
2. Research and development to meet health needs in developing countries: strengthening global financing and coordination. Report of the Consultative Expert Working Group on Research and Development: Financing and Coordination Geneva: World Health Organization; 2012. http://www.who.int/phi/CEWG_Report_5_April_2012.pdf?ua=1
3. Follow-up of the report on the Consultative Expert Working Group on Research and Development: financing and coordination. http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_28Add1-en.pdf
4. Røttingen JA, Chamas C, Goyal LC, Harb H, Lagrada L, Mayosi BM, Securing the public good of health research and development for developing countries. Bull World Health Organ 2012; 90(5):398–400 doi: 10.2471/BLT.12.105460 22589577
5. Commission on Macroeconomics and Health. Macroeconomics and health: investing in health for economic development. Geneva: World Health Organization; 2001 12396642
6. Jamison DT, Summers LH, Alleyne G, Arrow KJ, Berkley S, Binagwaho A, et al. Global health 2035: a world converging within a generation. The Lancet 2013; 382(9908): 1898–955
7. Outterson K, New Business Models for Sustainable Antibiotics. Chatham House, London: Royal Institute of International Affairs; 2014
8. Røttingen JA, Regmi S, Eide M, Young AJ, Viergever RF, Årdal C, et al. Mapping available health R&D data: what’s there, what’s missing and what role for a Global Observatory. Lancet 2013; 382(9900):1286–307 doi: 10.1016/S0140-6736(13)61046-6 23697824
9. Grogan K. AMR review head O'Neill calls for $2 billion innovation fund. Pharma times. http://www.pharmatimes.com/Article/15-02-27/AMR_review_head_O_Neill_calls_for_2_billion_innovation_fund.aspx. Accessed 19 March 2015
10. Yamey G, Campe S, Fewer S, Germany, the G7, and global health. BMJ 2015; Mar 5;350:h1210. doi: 10.1136/bmj.h1210 25744556